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Introduction 
Recurrent  Miscarriage  (RM)  is  referring  to  ≥3 
consecutive  fetus  losses  in  first-trimester  or  ≥2  in 
second-trimester.  By  means  of  this  definition,  RM 
involves  1-2%  of  all  couples  trying  pregnancy.
1 
Although the frequency of 3 miscarriages accidentally 
is  approximately  0.34%,  the  possibility  of  a 
spontaneous  miscarriage  is  about  12–14%.
2-3  This 
discrepancy  indicates  that,  besides  accidental  causes, 
risk of RM is increased in some couples pathologically 
as a result of genetic disorders or anatomical, infectious 
and  endocrine  complications.  In  about  50%  of  RM 
cases,  the  etiology  still  remains  unknown.
4 
Immunological  factors  play  a  significant  role  in  RM 
etiology  since  the  fetus  and  placenta  are 
immunologically different from the mother.
5 
Fetus  is  considered  as  a  semiallograft  for  maternal 
immune system, and ordinarily, the mother would be 
expected to produce antibodies and CTL (cytotoxic T 
lymphocytes) to foreign paternal HLA or other antigens 
expressed by fetal cells.
6 Thus, particular mechanisms 
must modulate the maternal immune system in favor of 
success of pregnancy, so that help fetus resides inside 
the uterus for 9 months.
7 
several  mechanisms  protect  the  semiallogeneic  fetus 
from  maternal  graft  rejection  responses.
6  These 
strategies  include  lack  of  any  physical  connection 
between maternal and fetal tissues and fully separation 
of  the  blood  circulations;  lack  of  fetal  antigens  that 
could  cause  graft  rejection;  late  appearance  of 
transplantation  antigens  in  the  fetus; 
immunosuppression of leukocytes which present at the 
maternofetal interface; development of tolerance, build 
up the pregnant uterus as an immune privileged site by 
both  the  fetus  and  the  mother.
6  Failure  in  these 
mechanisms  may  cause  complications  in  pregnancy 
like maternal rejection of the embryo/fetus.
7 
Immunosuppression of leukocytes which present at the 
maternofetal  interface  is  one  of  the  mechanisms  that 
might  modulate  maternal  immune  responses  during 
pregnancy.
8  HLA-G,  Non-classical  class  Ib  human 
leukocyte antigen (HLA) molecules, is believed to be 
involved  in  this  immunosuppression.  As  HLA-G  is 
expressed on trophoblast cells in the placenta,
9 it seems 
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Because mothers and fathers are more or less dissimilar at multiple HLA loci, mother 
considers her fetus as a semi-allograft. Mother's immune system may recognize paternal 
HLA as foreign antigen and may develop anti-paternal HLA antibodies and cytotoxic T 
lymphocyte.  There  are  some  mechanisms  that  modulate  maternal  immune  responses 
during  pregnancy,  in  order  to  make  uterus  an  immune  privileged  site.  This 
immunosuppression is believed to be mediated, at least partly, by HLA-G, non-classical 
class  I  human  leukocyte  antigen  (HLA)  molecule  that  is  strongly  expressed  in 
cytotrophoblast and placenta. The major HLA-G function is its ability to inhibit T and B 
lymphocytes, NK cells and antigen-presenting cells (APC).Since HLA-G is expressed 
strongly at the maternofetal interface and has an essential role in immunosuppression, 
HLA-G polymorphism and altered expression of HLA-G seems to be associated with 
some  complications  of  pregnancy,  such  as  pre-eclampsia,  recurrent  misscariage  and 
failure  in  IVF.This  perspective  discusses  recent  findings  about  HLA-G  genetics, 
function, expression and polymorphism; and focus on HLA-G role in the etiology of 
recurrent miscarriage.  
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to be occupied in development of pregnant uterus as an 
immune  privileged  site.
6  Accordingly,  diminished  or 
aberrant  HLA-G  expression  may  involve  in  the 
etiology  of  immunological  malfunction,  like  pre-
eclampsia,  recurrent  miscarriage  and  implantation 
failure in IVF.
5,7 
HLA  antigens  are  most  powerful  cause  of  graft 
rejection.  Although  anti-paternal  HLA  antibodies  are 
detectable  in  pregnant  women's  sera,  they  do  no 
damage  and  they  are  more  tolerogenic  rather  than 
immunogenic.
7 
The human major histocompatibility complex (MHC) 
genes are located on the short arm of chromosome 6 
and subdivided into class Ia, which includes HLA-A, -
B, and -C, and class II, which includes HLA- DR, -DQ 
and  -DP.  The  non-classical  HLA  class  Ib  genes 
encoding HLA-E, -G -H and –F that are clustered on 
chromosome  6p21  at  the  telomeric  end  of  the  MHC 
region. The HLA-G gene is located close to HLA-A 
and seems to have a close homology with that.
10 
HLA class Ib antigens are similar to the HLA class Ia 
antigens in some characteristics, but also differ from 
them in several major features, including: 1) HLA class 
Ia genes are highly polymorphic, with so many alleles, 
but  HLA  class  Ib  genes  are  distinguished  by  low 
numbers  of  alleles,  for  example  HLA-G  is  almost 
monomorphic and has ﬁve alleles.
11 2) All HLA class 
Ia antigens are membrane bound, but one member of 
the class Ib group has soluble isoforms too, for example 
HLA-G have seven alternatively spliced transcripts that 
encoded  four  membrane  bound  and  three  soluble 
proteins.  3)  The  expression  of  class  Ia  antigens  is 
ubiquitous  while  expression  of  class  Ib  antigens  is 
organ-speciﬁc and conditional. 
Structural features of HLA-G is similar to other class I 
genes.  It  has  eight  exons;  exon  1  encodes  a  signal 
peptide,  exons  2,  3,  and  4,  encode  external  part 
(respectively α1, α2 and α3 domains), exon 5 encodes 
transmembrane  domain  and  exons  6  and  7  encode 
intracellular domain.
12 α1 and α2 domains construct the 
peptide-binding cleft and α3 domain is binding site for 
leukocyte Ig-like receptor 1 and 2 (LIR-1 and LIR-2), 
which are inhibitory receptors. HLA-G has two unique 
characteristic;  first,  a  stop  codon  in  exon  6  cause  a 
shortened cytoplasmic tail that results in the prolonged 
expression of HLA-G at the cell surface, and inefﬁcient 
presentation of exogenous peptides.
10 Second, due to 
mRNA alternative splicing, HLA-G encodes multiple 
isoforms  including  four  membrane-bound  isoforms, 
HLA-G1 to -G4, and three soluble isoforms, HLA-G5 
to -G7.
13,14 
Trophoblast  cells,  which  originate  from  the  fetus, 
regulate  their  expression  of  HLA  genes  and  the 
production of their proteins. If these proteins recognize 
by  maternal  immune  cells  as  foreign  antigens,  they 
would stimulate maternal CTL against fetal antigens, so 
destroy fetal cells which express HLA. In contrast, the 
antigens expressed in trophoblast cells induce tolerance 
in maternal leukocytes. A successful pregnancy is due 
to  Th2  cytokine  profile  that  entitled  ‘Th2 
phenomenon’,  while  Th1  response  may  cause  some 
complications of pregnancy, such as RM.
15 
Except  HLA-C  which  may  has  weak  expression  on 
trophoblast cells, other HLA class Ia and II antigens are 
not expressed by these cells.
16 Hence, the fetal cells are 
not in direct contact with the maternal immune system. 
Although NK-cell will destroy cells that do not express 
MHC, the strong expression HLA-G on cytotrophoblast 
cells, in cooperation with the expression of HLA-E in 
the placenta, will prevent NK-mediated cell lysis.
7 
Even  though  HLA-G  mRNA  has  been  detected  in 
various  tissues,  the  HLA-G  protein  expression  is 
restrictive  and  strongly  expressed  on  invasive 
trophoblast  cells  of  the  placenta  at  the  maternofetal 
interface.
7 IL-10 can up-regulate HLA-G expression.
15 
The mouse monoclonal antibody W6/32 is used most 
regularly to identify HLA-G antigens.
6,17 sHLA-G can 
be  detected  in  serum/plasma  from  both  women  and 
men.
18 Monocytes are the main source of sHLA-G in 
the blood of men and non-pregnant women.
7 Although 
sHLA-G can only be detected in some serum samples, 
it is detectable in all plasma samples from non-pregnant 
and  pregnant  women;  hence  plasma  samples  are 
preferred. HLA-G polymorphisms may effect the level, 
or even the presence, of sHLA-G in serum/plasma.
18 
HLA-E in another class Ib MHC that is expressed by 
trophoblasts.
10 Its binding site has a great affinity for 
the HLA-G signal peptide, and this binding plays an 
important role in HLA-E expression on the trophoblast 
cell surface. 
The  major  function  of  HLA-G  is  not  antigen 
presentation;  it  may  play  a  significant  role  in 
immunosuppression  and  tolerance  (Figure1).
9 
Therefore,  HLA-G  is  somehow  essential  to  immune 
privilege in pregnancy.
6 HLA-G as an inhibitory ligand 
for natural killer cells and cytotoxic T-lymphocytes can 
inhibit  CTL  responses  and  NK  functions,
19  both 
through direct interaction with the receptors LIR-1 and 
LIR-2 and with the killer Ig-like receptor 2 (KIR2),
20 
hence  may  protect  trophoblasts  via  these  receptors.
21 
Additionally,  antigen-presenting  cells  (APC),  which 
have been transfected with HLA-G, are able to inhibit 
the  proliferation  of  CD4+  T  cells  that  leads  to 
suppression  in  T  helpers.
22  Besides,  soluble  HLA-G 
(sHLA-G) can induce apoptosis in CD8+ T-cell.
23  
HLA-E is also help the fetus to avoid maternal immune 
surveillance,  possibly  by  interacting  with  the 
CD94/NKG2A, NK-cell inhibitory receptor.
24 HLA-E 
is the most important ligand for the inhibition of NK 
cells.
10 
In contrast to the highly polymorphic HLA class Ia and 
II, the gene polymorphism of the HLA class Ib is very 
sparse as HLA-G proteins are almost monomorphic.
7 
Most polymorphisms in the HLA-G gene do not alter 
the amino acid sequence; and some polymorphisms that 
do  alteration  are  not  change  secondary  structures.
11 
However, some of these polymorphisms in regulatory 
regions of the HLA-G gene may influence transcription  
|   445  Advanced Pharmaceutical Bulletin, 2013, 3(2), 443-446  Copyright © 2013 by Tabriz University of Medical Sciences 
Pregnancy outcome prediction using HLA-G expression pattern 
and  mRNA  abundance
25  and  subsequently  HLA-G 
expression.
18,26 
Some investigations carry out in order to find out if 
expression of HLA-G at the maternofetal interface in 
women  with  RM  is  different  in  comparison  with 
normal pregnancies. Results indicated that expression 
pattern of HLA-G is associated with a risk of RM.
25 
sHLA-G levels in the serum of women  experiencing 
RM in comparison with serum sHLA-G concentration 
of  women  with  successful  pregnancies  were 
significantly lower.
18 
Although all evidences support the imperative role for 
HLA-G  in  maternal  immunosuppression  during 
pregnancy,  in  vivo  experiments  must  be  done  to 
confirm this evidences. Since significance of HLA-G 
expression  in  pregnancy  is  proved,  more  research  is 
needed  to  elucidate  the  molecular  mechanisms 
associated with HLA-G expression and function.   
 
 
Figure 1. Expression HLA molecules during pregnancy and interactions between HLA class Ib molecules, natural killer (NK) receptors 
and cytokines at the feto–placental interface. The fetus inherits one HLA haplotype from the mother and one from the father and is 
thereby semiallogenic for the mother. However, the extreme polymorphic classical HLA class Ia and II antigens, HLA-A, -B and –DR, are 
not expressed by the trophoblast cells in the placenta. Instead, the nearly monomorphic non-classical HLA class Ib antigens, especially 
HLA-G, are expressed on the invasive cytotrophoblast cells. In this way, the trophoblast cells escape NK-cell-mediated lysis. Membrane-
bound and soluble HLA-G (sHLA-G) can influence cytokine secretion and an allo-cytotoxic Tlymphocyte (CTL) response as described in 
detail in the text. *, ILT-4 is expressed on monocytes, macrophages and dendritic cells.
7 
 
According  above,  measuring  of  levels  of  HLA-G 
isoforms may be practical marker for the prediction of 
mother's  capability  to  tolerate  semiallograft  fetus, 
success in IVF treatments and graft acceptance. 
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